Avery Catlin - May 17, 2022 Form 4 Insider Report for Provention Bio, Inc. (PRVB)

Role
Director
Signature
/s/ Thierry Chauche, as attorney-in-fact
Stock symbol
PRVB
Transactions as of
May 17, 2022
Transactions value $
$0
Form type
4
Date filed
5/18/2022, 06:04 PM
Previous filing
Jun 17, 2021
Next filing
May 19, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PRVB Stock Option (right to buy) Award $0 +33K $0.00 33K May 17, 2022 Common Stock, par value $0.0001 33K $4.52 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The options will vest in full and become exercisable upon the earlier to occur of (a) the business day before the Issuer's next annual meeting of stockholders and (b) May 17, 2023.
F2 The securities were granted pursuant to the Issuer's Amended and Restated 2017 Equity Incentive Plan.

Remarks:

Exhibit 24.1 - Power of Attorney